Live Breaking News & Updates on Clinical research malaysia

Stay informed with the latest breaking news from Clinical research malaysia on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinical research malaysia and stay connected to the pulse of your community

Here's how we can achieve nimbleness, self-sufficiency, Khairy

Here's how we can achieve nimbleness, self-sufficiency, Khairy
themalaysianinsight.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themalaysianinsight.com Daily Mail and Mail on Sunday newspapers.

Malaysia , Thailand , Singapore , Malaysian , Pfizer , Clinical-investigation-centre , Institute-of-medical-research , Clinical-research-malaysia , World-health-organization , Cambridge-society-malaysia , Coalition-for-epidemic-preparedness-innovations

Malaysia working on two vaccines for Covid-19

PETALING JAYA: Made-in-Malaysia Covid-19 vaccines could be a reality in the future as the Institute for Medical Research (IMR) is currently developing two types of vaccines, says the Health Ministry.

Malaysia , Petaling , Malaysia-general , Malaysian , Adham-baba , Institute-for-clinical-research-malaysia , Institute-for-medical-research , National-science-council , Health-ministry , Medical-research , Datuk-seri-dr-adham-baba , National-vaccine-development-roadmap

Doctors: Seriously ill should not shun hospitals for fear of Covid-19 | Malaysia

Friday, 22 Jan 2021 05:12 AM MYT
BY R. LOHESWAR
A general view of the Sungai Buloh Hospital January 29, 2020. Health experts had predicted that hospitals would be overrun if cases hit the 5,000 to 8,000 per day mark. — Picture by Hari Anggara
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Jan 22 — Patients who need health treatment for serious illnesses must not delay this notwithstanding the advice to avoid hospitals due to possible Covid-19 risks, several doctors said.
They stressed that the recommendation was against unnecessary trips to hospitals and should not be interpreted as a suggestion to put off treatment.

Malaysia , Kuala-lumpur , Medan , Sumatera-utara , Indonesia , Sungai-buloh , Malaysia-general , Malaysians , Klinik-kesihatan-taman , Rohans-shanmuganathan , Noor-hisham , Arvinder-singh

Hospitals overrun if Covid-19 spikes in March, health experts urge new quarantine centres and local task forces | Malaysia

Sunday, 10 Jan 2021 06:55 AM MYT
BY R. LOHESWAR
Health director-general Tan Sri Dr Noor Hisham had recently said that according to prediction models, cases will hit 8,000 per day if the basic reproduction number (R-nought or R0) of the virus infection increases to 1.2. — Bernama pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Jan 10 — Existing medical facilities in the country will be overwhelmed if Covid-19 cases spike in March to an estimated 8,000 cases a day, several medical experts polled by
Malay Mail have warned.
In order to help contain the infections, they suggested that the federal government set up more quarantine centres in each state, and work closely with the state agencies to better reach the masses who are in need of urgent care.

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Arvinder-singh , Helmy-haja-mydin , Economic-research-initiative-seri , Malaysian-medical-association , Health-ministry , Institute-of-clinical-research-malaysia

Private sector players look to fill vaccine supply gap

AHEAD of an anticipated mass roll-out of Covid-19 vaccines in Malaysia next year, private sector players are positioning themselves to fill any gaps in the vaccine supply chain, notwithstanding Putrajaya’s supply arrangement with Pfizer and the Covid-19 vaccine global access (COVAX) facility.
Comments by Minister of Science, Technology and Innovation Khairy Jamaluddin that vaccine arrangements by private companies are purely commercial deals and not related to the government have not dimmed private sector interest in the Covid-19 vaccine supply.
Local companies that have jumped onto the bandwagon say they are not unduly worried, as they believe they have a role to play in the supply chain, particularly if they are able to obtain vaccines that are safer or more affordable.

China , Malaysia , Yong-tai , Shaanxi , United-kingdom , Shenzhen , Guangdong , Chinese , Malaysians , Muhyiddin-yassin , Khairy-jamaluddin , Pharmaniaga-bhd

With no silver lining seen in tourism and property, Yong Tai banks on vaccine move

LIKE many companies, Yong Tai Bhd has not been spared from the adverse impact of the Covid-19 pandemic, due to its presence in the tourism and property sectors. With no silver lining in sight for the next two years, the company has had no choice but to invest in new business opportunities.
It hopes that its plan to distribute a Covid-19 vaccine announced earlier this month will be its turning point. “Today, we cannot keep pumping money into the property sector. Good money should not be put into a risky business or bad industry anymore. Proceeds from the fundraising should be used in the right industry,” Yong Tai CEO Datuk Wira Boo Kuang Loon tells The Edge in an interview.

China , Melaka , Malaysia , Kuala-lumpur , Yong-tai , Shaanxi , Shenzhen , Guangdong , Sdn-bhd , Amber-cove , Yong-tai-bhd , Kinsel-sdn-bhd

Vaccine trials in Malaysia

Dr Akhmal: ‘While we wait for a Covid-19 vaccine to be procured, distributed, and administered to our population, clinical research is an important step to ensure that the vaccine fulfils the requirement of the regulatory authorities which looks at its safety, quality, and efficacy.’
MALAYSIA is now seeing the initiation of the first Covid-19 vaccine trial in the country.
“It is a Phase 3 vaccine trial, by the Institute of Medical Biology, Chinese Academy of Medical Sciences. The trial application is currently ongoing for review and approval by the regulatory authority and ethics committee before being conducted in our hospitals here, ” says Dr Akhmal Yusof, CEO of Clinical Research Malaysia (CRM).

China , Malaysia , Malaysian , Chinese , Muhyiddin-yassin , Dina-murad , Akhmal-yusof , Technology-ministry , Foreign-affairs-ministry , Clinical-research-malaysia , Chinese-academy-of-medical-sciences , Health-ministry